Fig. 2

Example of model outcomes in three test scenarios. Scenarios tested were endemic equilibrium (top), combined ring treatment (middle), and combined mass treatment (bottom), and outcomes shown are porcine cysticercosis (left) and human taeniasis (right). For each scenario the model was calibrated to a baseline prevalence 23.2% for porcine cysticercosis and 2.9% for human taeniasis. Intervention settings for ring treatment: 87% treatment efficacy for human taeniasis (2-dose niclosamide); 100% treatment efficacy for porcine cysticercosis (oxfendazole); 91% sensitivity of tongue inspection; 85% participation among humans in rings, 60% pig participation. Intervention settings for mass treatment: 77% treatment efficacy for human taeniasis (1-dose niclosamide); 100% treatment efficacy for porcine cysticercosis (oxfendazole); 75% participation among all humans; 60% participation among all pigs